1. Augustine, A, Hebert, JR, Kabat, GC & Wynder, EL (1988). Bladder cancer in relation to cigarette smoking. Cancer Res 48: 4405–4408.
2. Bartsch, H, Malaveille, C, Friesen, M, Kadlubar, FF & Vineis, P (1993). Black (ari-cured) and blond (flue-cured) tobacco cancer risk IV: molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 29A: 1199–1207.
3. Bell, DA, Taylor, JA, Butler, MA, Stephens, E, Wiest, J, Brubaker, L, Kadlubar, FF & Lucier, GW (1993). Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14: 1689–1692.
4. Bell, DA, Badawi, AF, Lang, NP, Ilett, KF, Kadlubar, FF & Hirvonen, A (1995a). Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55: 5226–5229.
5. Bell, DA, Stephens, EA, Castranio, T, Umbach, DM, Watson, M, Deakin, M, Elder, J & Berkowitz, RS (1995b). Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 55: 3537–3542.